LIVZON PHARMA

The company was founded in January 1985. It is a comprehensive pharmaceutical group company integrating R&D, production and sales of pharmaceutical products, and is an A+H listed company. The company regards R&D innovation as the cornerstone of sustainable development, and continues to pay attention to new molecules and cutting-edge technologies in the global field of new drug research and development. Based on clinical value, differentiated forward-looking layout of innovative drugs and complex formulations with high barriers, the company focuses on the digestive tract, assisted reproduction, psychiatry, tumor immunity, etc., and has formed a complete product cluster and a differentiated product pipeline covering the entire R&D cycle. The company's main business is R&D, production and sales of pharmaceutical products. The main products include iLianan, Rivolol series products, Rebelix, Vitrex, Beiyi, Lisenbao, Lebald, Lifecon, Ripple, Conertin, Shenqi Fuzheng injection, antiviral granules, etc.; mirvastatin, acarbose, colistin sulfate, phenylalanine, vancomycin hydrochloride, daptomycin, mirbetaxim and ceftriaxone sodium, etc.; Mycoplasma pneumoniae IgM antibody detection reagents, antibody test reagents for human immunodeficiency Diagnostic reagent products such as kits and antinuclear antibody test kits. Corporate honors: Pearl Delle won the first Grand Prize for Outstanding Contribution to Science and Technology Progress in Zhuhai; Pearl Dole won the Grand Prize for Outstanding Contribution to Promoting Scientific and Technological Progress in Zhuhai; Jinqi Fuzheng Injection won the first prize of the 2006 China Society of Integrative Traditional Chinese and Western Medicine Science and Technology Award, etc.